UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Albion Financial Group UT

Albion Financial Group UT cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.3% in the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 35,688 shares of the healthcare conglomerate’s stock after selling 834 shares during the quarter. UnitedHealth Group comprises 1.4% of Albion Financial Group UT’s holdings, making the stock its 22nd largest position. Albion Financial Group UT’s holdings in UnitedHealth Group were worth $17,655,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Alps Advisors Inc. grew its position in UnitedHealth Group by 111.0% during the 3rd quarter. Alps Advisors Inc. now owns 40,915 shares of the healthcare conglomerate’s stock worth $20,629,000 after purchasing an additional 21,526 shares during the period. Evergreen Capital Management LLC boosted its stake in shares of UnitedHealth Group by 3.2% during the 3rd quarter. Evergreen Capital Management LLC now owns 16,786 shares of the healthcare conglomerate’s stock worth $8,463,000 after acquiring an additional 519 shares in the last quarter. Elevatus Welath Management purchased a new position in UnitedHealth Group during the third quarter worth approximately $226,000. Legacy Advisors LLC raised its stake in shares of UnitedHealth Group by 7.3% during the 3rd quarter. Legacy Advisors LLC now owns 15,667 shares of the healthcare conglomerate’s stock worth $7,899,000 after buying an additional 1,062 shares during the period. Finally, Lakeshore Financial Planning Inc. purchased a new stake in UnitedHealth Group in the 3rd quarter worth $313,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the company. Royal Bank of Canada cut their price objective on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research note on Wednesday, April 17th. Baird R W upgraded UnitedHealth Group to a “strong-buy” rating in a report on Thursday, May 30th. Wells Fargo & Company lowered their price objective on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research note on Monday, April 8th. Piper Sandler raised their price objective on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Finally, StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Friday, June 28th. Three investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $579.74.

UnitedHealth Group Price Performance

UNH stock opened at $489.90 on Thursday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The business has a 50 day moving average price of $498.64 and a 200 day moving average price of $501.12. The stock has a market cap of $450.90 billion, a price-to-earnings ratio of 29.94, a PEG ratio of 1.47 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. UnitedHealth Group’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period last year, the business earned $6.26 EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.55 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were issued a $2.10 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 annualized dividend and a dividend yield of 1.71%. The ex-dividend date of this dividend was Monday, June 17th. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.